TODAY -

Drug-resistant TB: Are we converting scientific breakthroughs into public health gains?

Bobby Ramakant *



Undoubtedly, among the most important scientific breakthroughs for the diagnosis and treatment of drug-resistant tuberculosis (TB) have happened in the past few years. But are we able to convert the scientific breakthroughs into public health gains quickly enough - by diagnosing every person with drug-resistant TB, and treating them with safe and effective medicines?

Science has proven that it is possible to reduce the duration of treatment of highly drug-resistant forms of TB from around 2 years to 6 months, reduce toxicity of the medicines, and significantly improve treatment outcomes. A big challenge indeed is to translate these scientific advancements into public health gains. Clock is ticking!

Know more on drug resistance

“Antimicrobial resistance, also known as drug resistance, makes an infectious agent (such as TB causing bacteria) resistant to medicines. So, when TB bacteria becomes resistant to a medicine, then it cannot be killed by it. That is why, we need a different combination of medicines (to which bacteria is sensitive to) to treat the disease. Choice of medicines left to treat is limited, treatment is longer, risk of severe illness and dying is higher, and host of issues such as, drug toxicity, side effects, and sometimes post-treatment disabilities, are other challenges.

But there is good news too – thanks to rigorous scientific research, we have shorter, safer, and more effective therapies for treating drug-resistant TB now. We need to ensure that standard and best possible treatment options reach everyone in need without any delay. No excuse for inaction,” said Shobha Shukla, founder Executive Director of CNS who was moderating The Dose Podcast.

The Dose Podcast

The latest episode of The Dose Podcast, which premiered on 2022 World TB Day (launched by the Working Group of New TB Drugs of Stop TB Partnership), featured two TB science leaders who have been instrumental in advancing scientific research for highly drug-resistant TB.

“Highly drug-resistant TB as it was referred to in the Nix-TB and ZeNix scientific studies, was the combination of either XDR-TB or pre-XDR-TB (using the pre-2021 definitions) or MDR-TB with treatment intolerance or non-responsive MDR-TB,” said Dr Gustavo Velasquez, Assistant Professor in the Division of HIV Infectious Diseases and Global Medicine at University of California.

Watershed moment: Increasing treatment success rate from 58% to 90%

“Treatment success for highly drug-resistant TB has been highly variable over time and very specific to cohorts and geography. Latest WHO Global TB Report (of 2021) cited data from across the world that the treatment success rate for MDR-TB was 59% in 2018,” said Dr Gustavo. Treatment success rate for MDR-TB in 2012 was around 50%.

But two studies (Nix-TB and ZeNix) have provided strong scientific evidence that treatment success rate can be much better (90%).

90% treatment success rate for drug-resistant TB

“The Nix-TB study showed an extraordinarily high rate of success [with BPaL regimen of Bedaquiline, Pretomanid and Linezolid]. I work in South Africa and at that time the success rate for those with highly drug-resistant TB was less than 40%. The Nix-TB study showed that we could successfully treat 90% of our patients with the short all-oral regimen,” said Dr Francesca Conradie, who is the principal investigator of the two studies (Nix-TB and ZeNix) that have evaluated one of the most promising treatment options for people with highly drug-resistant TB (BPaL regimen with Bedaquiline, Pretomanid and Linezolid drugs).

Ninety percent treatment success rate for highly drug-resistant TB has given a new hope to many.

“I think this was a watershed moment in the treatment of drug-resistant TB but it did come at a cost. There was a high rate of adverse events associated with the older drug used in this regimen – Linezolid. Because of higher dosage of Linezolid, we saw a frequent occurrence of peripheral neuropathy. We had two cases of optic neuropathy and more cases when Linezolid suppressed the bone marrow (which resulted in drop of haemoglobin),” said Dr Francesca.

Safer, all-oral and more effective treatment becomes even better!

Following Nix-TB study, another study called ZeNix study aimed to find if it was possible to maintain high rate of 90% efficacy but also increase the safety (by looking at various doses of Linezolid that caused adverse events in Nix-TB study).

ZeNix study had 4 groups of people who got BPaL (Bedaquiline, Pretomanid and Linezolid) regimen for six months but there were differences in dosage and duration of Linezolid given.
- In the first group, 1200mg of Linezolid was part of the regimen for entire six months
- In the second group, 1200mg of Linezolid was part of the regimen for the two months
- In the third group, 600mg of Linezolid was part of the regimen for entire six months
- In the fourth group, 600mg of Linezolid part of the regimen for two months

“What was striking about ZeNix study is that it demonstrated that the Nix-TB study was not a flash-in-the-pan. Across the four groups, the rate of treatment success was around 90%. We also noted that with the decreasing dose and duration of Linezolid while maintaining the efficacy of the regimen, we saw a decrease in the adverse events,” informed Dr Francesca.

ZeNix study was conducted in European nations as well as South Africa, and higher treatment success rate was seen in all study sites.

“Many of the patients that I treat have very poor social circumstances and the quicker that we can get them treated and back into the communities the better” said Dr Francesca underlining the importance of six-months, all-oral and highly effective regimen for people with highly drug-resistant TB.

ZeNix study also shows that HIV positive patients with highly drug-resistant TB who are on antiretroviral therapy (and virally suppressed), do as well with BPaL regimen as those who are not HIV co-infected. “So, being HIV co-infected is not an indication for not giving this particular regimen,” said Dr Francesca.

The US FDA had approved BPaL regimen for treating highly drug-resistant TB, followed by the WHO that issued consolidated 2020 TB guidelines recommending 6 to 9 months of BPaL regimen under operational research conditions for treating highly drug-resistant TB.

“ZeNix has contributed very important new evidence on the dose and duration related toxicities of Linezolid,” said Dr Gustavo in The Dose Podcast.

He cautioned: "For treatment of highly drug-resistant TB globally, Linezolid remains a toxic drug. It will continue to be important to think about how we will monitor and manage Linezolid toxicity in programmatic settings. Evidence provided by the ZeNix study is important. I hope it will also be complemented by ongoing studies that are going to further look at optimization of Linezolid in this type of regimen but also in different combination of drugs."

Low diagnostic capacity to detect drug resistance cripples us further

Important new diagnostics for highly drug-resistant TB have come forth in the last decade. Gene Xpert, Xpert Ultra to Xpert XDR, are among the technological advancements that have made it possible to detect drug resistance quickly and accurately. But molecular diagnostics to detect resistance against new medicines like Bedaquiline for example, are yet to come. As of now, we have the older phenotypic methods which takes six to eight weeks for results to come.

“The diagnosis of Bedaquiline resistance is laborious. At this stage there is no molecular diagnostics to detect Bedaquiline resistance. In our BPaL clinical access programme in South Africa we have enrolled 70 patients. We have detected two patients with Bedaquiline resistance. Both of them have been exposed to Bedaquiline for a short period of time and were lost to the programme because of COVID-19,” said Dr Francesca. “Bedaquline has a very long half-life so particularly if you are lost to the programme early on in treatment you end up being on Bedaquiline monotherapy for a while.”

There was another study published by Dr Nazir A Ismail from National Institute for Communicable Diseases, Johannesburg, South Africa, in which about two percent of patients with rifampicin-resistant TB had concomitant Bedaquiline resistance.

Dr Gustavo rightly pointed out that more work needs to be done to scale up latest diagnostic technologies worldwide. While we are rightly demanding latest molecular diagnostics to be accessible and available everywhere, the ground reality is that not even phenotypic testing is widely available everywhere.

Time to act is now!

"The time for action is here. There is sufficient clinical trial data for us to start implementing better treatment options in select populations," asserts Dr Francesca.

"We hope that the new regimens on the horizon will mean relief for people with highly drug-resistant TB, reduce human pain and suffering, and avert untimely deaths," said Shobha Shukla, who also leads Asia Pacific Media Alliance for Health and Development.

Definitions of MDR-TB, XDR-TB and Pre-XDR-TB:

- When TB bacteria is resistant to two of the most potent first-line anti-TB drugs, Isoniazid and Rifampin (outside of the US this medicine is called Rifampicin) then it is referred to as multidrug-resistant TB (MDR-TB).

- When in addition to Isoniazid and Rifampin, the TB bacteria also gets resistant to fluroquinolones and second-line injectables, then it is referred to as extensively drug-resistant TB (XDR-TB).

- If TB bacteria is resistant to Isoniazid and Rifampin, and in addition to either fluoroquinolones or second-line injectable, then it is referred to as Pre-XDR-TB.

Definitions of XDR-TB and Pre-XDR-TB went some change in January 2021 because all-oral regimen became a reality (and second-line injectables are no longer as highly prioritised, thankfully!). Now, XDR-TB is defined as resistance to Isoniazid and Rifampin, fluoroquinolones, and at least one other group of drugs, or drug (Bedaquiline or Linezolid). Pre-XDR-TB is a simpler definition now because it is resistance to Isoniazid and Rifampin, and fluoroquinolones.


* Bobby Ramakant wrote this article for e-pao.net
The writer is a World Health Organization (WHO) Director General’s WNTD Awardee 2008 and part of Editorial of CNS (Citizen News Service).
Follow him on Twitter @BobbyRamakant
This article was webcasted on April 24 2022.



* Comments posted by users in this discussion thread and other parts of this site are opinions of the individuals posting them (whose user ID is displayed alongside) and not the views of e-pao.net. We strongly recommend that users exercise responsibility, sensitivity and caution over language while writing your opinions which will be seen and read by other users. Please read a complete Guideline on using comments on this website.




LATEST IN E-PAO.NET
  • ILP Check point at Jiri : Gallery
  • COVID-19 Status 27 June : Govt of Manipur
  • The untold story, lest it be forgotten
  • Assistance to victims of Assam Flood
  • A glimpse of 'Yangna Paikhredako Punshi'
  • Market innovations in developing country
  • COVID-19 : Impact in Manipur :: News Timeline
  • Anti-drug day expose state pathetic situation
  • The wedge amongst the Nagas
  • Coming of Manipur University in 1980
  • COVID-19 Status 26 June : Govt of Manipur
  • Laitonjam Lanchenba: Best Swimmer
  • Our capital Imphal - the city of sanity
  • Workshop : ND & PS Act, 1985
  • Mara Prabhu - Lord of the trees
  • Essence of international anti-drug day
  • July 1 : Taking the fight to plastic
  • Miss Shirui Lily 2022 #3 : Gallery
  • COVID-19 Status 25 June : Govt of Manipur
  • Flesh Trade : Connection between Goa & NE
  • Importance of Soil Testing & Management
  • ST status Vs Classical language for Meetei
  • Life, faith and belief
  • MANISFA General Secretary appointed
  • Flood Watch : 23rd June #2 : Gallery
  • COVID-19 Status 24 June : Govt of Manipur
  • Community led in ensuring HIV treatment
  • Approach to ideology & development
  • Solar Energy solution for healthcare facility
  • Yoga for health, beauty and immunity
  • Innovation Prize Launched for Designers
  • Knotty higher education sector
  • Classical language status and ST demand
  • Flood Watch : 23rd June #1 : Gallery
  • COVID-19 Status 23 June : Govt of Manipur
  • Birds and Bees Talk launched 3rd phase
  • Luck matters, Rio's first entry into cabinet...
  • Need to deal with dumping of waste materials
  • Training on mushroom at Nagamapal
  • 1961 as base year: Take it or leave it
  • 10 years too late : JCILPS
  • Phamnaiba Jagoi @ Thangjing : Gallery
  • COVID-19 Status 22 June : Govt of Manipur
  • Women's cleanliness enjoys equal rights...
  • Life in some hill villages
  • The MCI Restoration II
  • 'BRO Cafes' on 75 border roads
  • Protest over boundary row headache for Govt
  • Issues on the indigenous question
  • Drug Menace In Manipur : Gallery
  • COVID-19 Status 21 June : Govt of Manipur
  • ST tag for Meiteis - A perspective!
  • Manipur State Welfare : Politics 1-0 Citizens
  • International Yoga Day at Assam Rifles
  • International Yoga Day at IBSD Imphal
  • International Yoga Day at NSU Imphal
  • Manipur Lokyukta: Fighting against corruption
  • Vision to distribute local rice under NFSA...
  • Taking the fight to the drug menace
  • Landslides - Imphal-Jiri [Jun 17] : Gallery
  • COVID-19 Status 20 June : Govt of Manipur
  • Thangjing in folklore of Koireng tribe
  • Health Workshop on Diabetes at Pune
  • Everyone is a thief :: Poem
  • E- barton for CM & Governor
  • Intensive cultivation of vegetables
  • High time to encourage e-vehicle operators
  • Scripting success story with Rs 500
  • Leima Jagoi by Transgender #1 : Gallery
  • COVID-19 Status 19 June : Govt of Manipur
  • June 19 2022 : Father's Day message
  • Nine Hills One Valley : Ottawa Film Fest
  • Shirui Lily Festival or mud festival ?
  • Yoga for Women organised
  • Flight link to Mandalay dream come true
  • Action of Govt needs to be backed
  • 21st Great June Uprising #1 : Gallery
  • COVID-19 Status 18 June : Govt of Manipur
  • The Great June 18 Uprising :: News Timeline
  • Revive environmentalism in Meetei ethos
  • COVID-19 Status 17 June : Govt of Manipur
  • Elephant army of Lord Guruvayurappan
  • Who will be next at Rashtrapati Bhawan
  • Hiyang Tannaba @ Loktak #1 : Gallery
  • Freedom movement against British #2
  • Inequity and health security
  • Donating blood is an act of solidarity
  • Unregulated deposit schemes & BUDS Act
  • Extension of entry age : Agnipath
  • Citizens feeding on adulterated food items
  • Of food safety and street vendors
  • Pooja Elangbam, IAS, 81st ranker in AICS
  • COVID-19 Status 16 June : Govt of Manipur
  • NE Model @Delhi Kids Fest : Gallery
  • Manipur Rajkunja
  • Effective Legal Aid to Women Prisoner
  • How to avoid cracked heel during hot summer
  • Aid to artisan must to promote local product
  • Education for whom ?
  • Kabui Dance @Nongshaba Haraoba : Gallery
  • COVID-19 Status 15 June : Govt of Manipur
  • 'Let's Talk About It' : music album
  • Significance of World Environment Day
  • The MCI Restoration
  • North East CSR Award 2022
  • Prolonged sitting or standing spoils your leg
  • State fast-tracking towards drug making hub
  • 'Progression' from smuggling to manufacturing
  • Bonny Elangbam : Longest distance covered
  • COVID-19 Status 14 June : Govt of Manipur
  • Interaction with Makakmayum Hosni Mubarak
  • India to become $5 trillion economy
  • Exploring traditional medicines of NE
  • Freefall of the kids after COVID-19
  • Honour the tax payers, expose defaulters
  • NE needs more than 'unprecedented'
  • Miss Shirui Lily 2022 #2 : Gallery
  • COVID-19 Status 13 June : Govt of Manipur
  • Water management in paddy cultivation
  • PM Modi hails Nagaland Gaon Burahs
  • Blight of Nature :: Poem
  • Moreh as Las Vegas
  • NHIDCL's reputation at stake
  • Drugs, poppy & 'alternatives'
  • Thaopai Shithaine of Poumai #2 :: Gallery
  • COVID-19 Status 12 June : Govt of Manipur
  • Jadonang Park, Tamenglong :: Gallery
  • Freedom movement against British #1
  • Multi-Tasking Staff at Leima Traders
  • Toning down rhetoric that hurts religion
  • Shirui Lily fest brings to fore plastic menace
  • Conservation of pony & grazing fields
  • Kakwa Lairembi Haraoba #2 :: Gallery
  • COVID-19 Status 11 June : Govt of Manipur
  • The unheeded cry of children in labour
  • Why present distribution of urea fails?
  • World Day Against Child Labour 2022
  • Sunrise on the Civil Aviation Horizon
  • Arambam Samarendra Ningshingba :: Gallery
  • COVID-19 Status 10 June : Govt of Manipur
  • NE Ex-Super Model at Delhi Kids Fest
  • What Diphu has, Dimapur & Kohima don't
  • Towards Manipur Budget 2022-23 ...
  • NE Social & Behaviour Change inaugurated
  • Fighting corruption remains an uphill task
  • Environment needs more than tree plantation
  • SN Chand: The father of Manipuri cinema #3
  • COVID-19 Status 09 June : Govt of Manipur
  • Degree Certificate for Survival #2
  • Value chain management of Umorok
  • Pulses for Nutrition Security in Manipur
  • Keeping your skin oil free during summer
  • Demand for impartial probe into IMC scam
  • Politics of isolating the NSCN (IM)
  • Raas @Manipur Rajbari, W Bengal :: Gallery
  • COVID-19 Status 08 June : Govt of Manipur
  • A rare book on Birds of Manipur
  • Condemns bomb blast in Manipur
  • Market Innovations made America great #2
  • Jal Jeevan Mission : PHED Manipur
  • Disturbing data on lifestyle diseases in state
  • Tough talk against drug menace
  • Trekking to Shirui Peak, Ukhrul #2 :: Gallery
  • COVID-19 Status 07 June : Govt of Manipur
  • Take a leaf from sunderban if you're serious
  • Testimony of brother Ninghor Mahongnao
  • Local leaders unitedly push for One Health
  • Letters from the Republic of Dust #2
  • Soil testing for better crop production
  • Despicable threat to school
  • Outrage at Little Flower School
  • Ibudhou Thangjing Lam Thokpa #3 :: Gallery
  • COVID-19 Status 06 June : Govt of Manipur
  • India-Taiwan Global Bamboo Tech Forum
  • Condemns bomb attack at LFS
  • RSS chief sounds logical
  • Career options in Environmental Science
  • We reap what we sow
  • NRC in focus as keyboard warriors spar...
  • Coming together of COCOMI, UNC
  • HSE Result 2022 : Statistiscal Abstract
  • HSE Result 2022 : Subject Pass Percentage
  • HSE Result 2022 : District-Wise Pass %
  • HSE Result 2022 :Science Topper
  • HSE Result 2022 : Arts Topper
  • HSE Result 2022 : Commerce Topper
  • HSE Result 2022 : Science Stream Result
  • HSE Result 2022 : Arts Stream Result
  • HSE Result 2022 : Commerce Stream Result
  • COVID-19 Status 05 June : Govt of Manipur
  • Nagaland: Is it fair to blame Indrajit Gupta ?
  • 4th Plenary Session of WMC at Sugnu
  • World Environment Day at Tamenglong
  • World Environment Day at Lilong
  • World Environment Day at Haraorou
  • Musing :: Poem
  • Yet another World Environment Day observed
  • Mounting pressure for solution
  • Padmashree Award Moirangthem Muktamani
  • COVID-19 Status 04 June : Govt of Manipur
  • Congested road at Shirui Village :: Gallery
  • Degree Certificate for Survival #1
  • Admission for National Sports University
  • World Environment Day at Imphal
  • Include Meeteis in the ST list
  • Inhumane act of De-addiction centres
  • UK band Monuments @ShiRock #2 :: Gallery
  • COVID-19 Status 03 June : Govt of Manipur
  • 'Provocation' charges arrests on social media
  • Gerinda Loitongbam: Natl Women Award
  • Timeless Memories :: Poem
  • Ket Meth releases music video Trauma'
  • 8 years of Modi Govt: More hits than misses
  • Bad example commanders
  • Posers parents may raise within
  • Miss Shirui Lily 2022 #1 : Gallery
  • COVID-19 Status 02 June : Govt of Manipur
  • Letters from the Republic of Dust #1
  • Workshop on Food Processing at Lilong
  • 1st June is the Global Day of Parents
  • 'Developing human resource in Manipur'
  • Swachh Bharat Mission (Grameen)
  • 'Yoga for personality development' orgd
  • Row over boundary fencing project
  • Brain storming session of the Congress
  • Lunghar (Imp-Kohima / Jessami) #3 : Gallery
  • COVID-19 Status 01 June : Govt of Manipur
  • Delphi Oinam : Topper at Nagaland HSLC
  • Teaching at Churachandpur Govt College
  • Jadonang Park at Tamenglong renovated
  • Quality seed production of rice (HYV)
  • Audiobook for NEET aspirants launched
  • Naga issue: From bush war to shadow boxing
  • Tenants in Nagaland tag on the NSCN (IM)
  • Wakhom Leikai Lairembi Haraoba #2 : Gallery
  • COVID-19 Status 31 May : Govt of Manipur
  • Pageant winners showcase Robert's collection
  • MIFF to pay homage to Irom Maipak
  • Awareness on Legal rights of women prisoner
  • Election petitions galore in Manipur
  • Training program on mushroom at Nagamapal
  • Must expedite process for border projects
  • Wanted : A far sighted leader
  • Naga Indigenous Wrestling :: Gallery
  • June Calendar for Year 2022 : Tools
  • UK band Monuments @ShiRock #1 :: Gallery
  • Ibudhou Thangjing Lam Thokpa #2 :: Gallery
  • SN Chand: The father of Manipuri cinema #2
  • Licypriya speech at East Timor :: Gallery
  • On 200th Anniversary of MK Binodini Devi
  • Featured Front Page Photo 2022 #2: Gallery
  • Harvesting Fest of Tarao #4 :: Gallery
  • Id-ul-Fitr @Hatta Golapati :: Gallery
  • Rules of English Pronunciation : Download
  • Sub-Syllables in English : Book Download